Cargando…

Rapid, Automated, and Specific Immunoassay to Directly Measure Matrix Metalloproteinase-9–Tissue Inhibitor of Metalloproteinase-1 Interactions in Human Plasma Using AlphaLISA Technology: A New Alternative to Classical ELISA

The protocol describes a novel, rapid, and no-wash one-step immunoassay for highly sensitive and direct detection of the complexes between matrix metalloproteinases (MMPs) and their tissue inhibitor of metalloproteinases (TIMPs) based on AlphaLISA(®) technology. We describe two procedures: (i) one a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pulido-Olmo, Helena, Rodríguez-Sánchez, Elena, Navarro-García, José Alberto, Barderas, María G., Álvarez-Llamas, Gloria, Segura, Julián, Fernández-Alfonso, Marisol, Ruilope, Luis M., Ruiz-Hurtado, Gema
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523156/ https://www.ncbi.nlm.nih.gov/pubmed/28791014 http://dx.doi.org/10.3389/fimmu.2017.00853

Ejemplares similares

Rapid, automated, parallel quantitative immunoassays using highly integrated microfluidics and AlphaLISA
por: Tak For Yu, Zeta, et al.
Publicado: (2015)

Comparison of AlphaLISA and RIA assays for measurement of wool cortisol concentrations
por: Peric, T., et al.
Publicado: (2020)

Development of an AlphaLISA assay for sensitive and accurate detection of influenza B virus
por: Zong, Huijun, et al.
Publicado: (2023)

Rapid and sensitive detection of botulinum toxin type A in complex sample matrices by AlphaLISA
por: Zhang, Liwen, et al.
Publicado: (2022)

AlphaLISA detection of alpha-synuclein in the cerebrospinal fluid and its potential application in Parkinson’s disease diagnosis
por: Zhao, Hongli, et al.
Publicado: (2017)

Quantification of Total and Mutant Huntingtin Protein Levels in Biospecimens Using a Novel alphaLISA Assay
por: Baldo, Barbara, et al.
Publicado: (2018)

Detection of Shiga Toxin 2 Produced by Escherichia coli in Foods Using a Novel AlphaLISA
por: Armstrong, Cheryl M., et al.
Publicado: (2018)

Development of a Cell-Based AlphaLISA Assay for High-Throughput Screening for Small Molecule Proteasome Modulators
por: Staerz, Sophia D., et al.
Publicado: (2023)

Development of a High-Throughput Homogeneous AlphaLISA Drug Screening Assay for the Detection of SARS-CoV-2 Nucleocapsid
por: Gorshkov, Kirill, et al.
Publicado: (2020)

Development of a high-throughput homogeneous AlphaLISA drug screening assay for the detection of SARS-CoV-2 Nucleocapsid
por: Gorshkov, Kirill, et al.
Publicado: (2020)

Characterization of the Humoral Immune Response to Porcine Epidemic Diarrhea Virus Infection under Experimental and Field Conditions Using an AlphaLISA Platform
por: Kimpston-Burkgren, Kay, et al.
Publicado: (2020)

Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay
por: Hanson, Quinlin M., et al.
Publicado: (2020)

Targeting ACE2–RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity Assay
por: Hanson, Quinlin M., et al.
Publicado: (2020)

Urinary alpha-1 antitrypsin and CD59 glycoprotein predict albuminuria development in hypertensive patients under chronic renin-angiotensin system suppression
por: Gonzalez-Calero, Laura, et al.
Publicado: (2016)

Ability of matrix metalloproteinase‐8 biosensor, IFMA, and ELISA immunoassays to differentiate between periodontal health, gingivitis, and periodontitis
por: Umeizudike, Kehinde Adesola, et al.
Publicado: (2022)

Adapting AlphaLISA high throughput screen to discover a novel small-molecule inhibitor targeting protein arginine methyltransferase 5 in pancreatic and colorectal cancers
por: Prabhu, Lakshmi, et al.
Publicado: (2017)

TCA Cycle and Fatty Acids Oxidation Reflect Early Cardiorenal Damage in Normoalbuminuric Subjects with Controlled Hypertension
por: Santiago-Hernandez, Aranzazu, et al.
Publicado: (2021)

In vitro validation of the tear matrix metalloproteinase 9 in-situ immunoassay
por: Bang, Seung Pil, et al.
Publicado: (2020)

Importance of tear volume for positivity of tear matrix metalloproteinase-9 immunoassay
por: Jun, Jong Hwa, et al.
Publicado: (2020)

LISA
Publicado: (2002)

The ADAM metalloproteinases
por: Edwards, Dylan R., et al.
Publicado: (2008)

Circulating Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Cardiac Amyloidosis
por: Tanaka, Komei, et al.
Publicado: (2013)

Comparison of Chemiluminescence Enzyme Immunoassay (Cl-ELISA) with Colorimetric Enzyme Immunoassay (Co-ELISA) for Imidacloprid Detection in Vegetables
por: Zhai, Rongqi, et al.
Publicado: (2023)

The regulation of trophoblast invasion and decidual reaction by matrix metalloproteinase‐2, metalloproteinase‐7, and metalloproteinase‐9 expressions in the rat endometrium
por: Hamutoğlu, Rasim, et al.
Publicado: (2020)

Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14
por: Buache, Emilie, et al.
Publicado: (2014)

Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Inflammation and Fibrosis of Skeletal Muscles
por: Alameddine, Hala S., et al.
Publicado: (2016)

Production of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Human Breast Carcinomas
por: Iwata, Hiroji, et al.
Publicado: (1996)

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
por: HOU, CHUN, et al.
Publicado: (2016)

Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Echinoderms: Structure and Possible Functions
por: Dolmatov, Igor Yu., et al.
Publicado: (2021)

Metal-linked Immunosorbent Assay (MeLISA): the Enzyme-Free Alternative to ELISA for Biomarker Detection in Serum
por: Yu, Ru-Jia, et al.
Publicado: (2016)

Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissuenhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase
por: Collins, H M, et al.
Publicado: (2001)

Tissue inhibitors of metalloproteinases
por: Murphy, Gillian
Publicado: (2011)

Matrix metalloproteinases and epileptogenesis
por: Ikonomidou, Chrysanthy
Publicado: (2014)

Metalloproteinases in Ovarian Cancer
por: Carey, Preston, et al.
Publicado: (2021)

Matrix Metalloproteinases and Glaucoma
por: Kim, Moo Hyun, et al.
Publicado: (2022)

Assessment of reliability and validity of the 5-scale grading system of the point-of-care immunoassay for tear matrix metalloproteinase-9
por: Kim, Minjeong, et al.
Publicado: (2021)

The Correlation between Matrix Metalloproteinase-9 Point-of-Care Immunoassay, Tear Film Osmolarity, and Ocular Surface Parameters
por: Kang, Min-Ji, et al.
Publicado: (2022)

Comparative Evaluation of Matrix Metalloproteinase-9 Immunoassay and Tear Osmolarity Measurement for Diagnosing Severity of Dry Eye Disease
por: Choi, Moonjung, et al.
Publicado: (2023)

Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases Are Essential for the Inflammatory Response in Cancer Cells
por: Sun, Jun
Publicado: (2010)

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in murine β-coronavirus-induced neuroinflammation
por: Sengupta, Sourodip, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jacjvpnl9aq9gaf3arn4e9k81l